无锡药明康德新药开发股份有限公司（股票代码：02359）于2026年6月9日公告，已于当日于香港联交所回购H股2,728,500股，约占前一交易日已发行股本（不包括库藏股份）500,541,409股的0.5451%。回购价格区间为每股港币111.5元至119.2元，合计耗资约3.15亿港元。
公告显示，截至6月9日收盘，公司已发行股本（不包括库藏股份）变更为497,812,909股，库藏股份从9,935,500股增至12,664,000股，总股份数维持510,476,909股不变。根据2026年4月28日通过的购回授权，公司可回购股数为298,375,715股，截至公告日，已在香港联交所及其他证券交易所累计回购12,664,000股，占购回授权通过日已发行股本的0.4244%。
公司确认，本次回购已遵循香港联合交易所有限公司证券上市规则及相关法律规定。该公告由公司董事李革签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.